PG's and Keratinocyte Adhesion

PG 和角质形成细胞粘附

基本信息

项目摘要

DESCRIPTION (provided by applicant): The candidate's goal is to advance her academic career by becoming a translational scientist through additional basic research and didactic training supported by a K08 Clinician-Scientist Development Award. The candidate is an Assistant Professor in the Clinician-Research-Teacher tenure-track at the University of Rochester School of Medicine, Department of Emergency Medicine. The candidate graduated from medical school in 1998 receiving an M.D. with Distinctions in Research, and since has successfully combined postdoctoral studies in basic research (80% effort) with clinical practice (20% effort). To reach her professional goal, the candidate proposes here a career development plan that will enable her to obtain additional training through coursework specifically designed to educate translational scientists as part of the curriculum available by the recently awarded CTSA NIH grant to our Institution. Moreover, the candidate will continue to pursue her successful research plan in skin cancer biology, coupled with advanced level courses in basic sciences. To this end, the candidate has discovered that in UV-induced skin cancers, the facilitative (pro-oncogenic) down-regulation of E-cadherin, an adhesion molecule mediating cell-cell contacts between keratinocytes, is a post-translational event consisting first of extracellular E-cadherin domain cleavage (primarily by MMPs), followed by endocytosis and proteolytic/ lysosomal-proteasomal degradation. Moreover, the candidate has discovered that this process is regulated by activation of the EP2 receptor by PGE2 released locally after UV radiation injury. As part of this K08 award, the candidate will continue her studies on this topic, which ultimately will lead to the identification of new targets for pharmacological intervention against UV-induced skin cancers. Completion of the proposed plan will enable the candidate to receive a Master's in Translational Science degree as part of her K08 award. Due to the diverse nature of the proposed training, the candidate has recruited a mentorial committee that provides the necessary mentorship, expertise and support. In conclusion, this K08 award will prepare the candidate for a career in basic/translational science, whereby she will be able to (1) identify novel scientific discoveries and their potential clinical usefulness in animal models (preclinical studies) in the laboratory, (2) evaluate such discoveries through clinical trials, and (3) bring their use to clinical practice (bench-to-bedside-to-curb).
描述(由申请人提供): 候选人的目标是通过K 08临床医生-科学家发展奖支持的额外基础研究和教学培训,成为一名翻译科学家,从而促进她的学术生涯。候选人是罗切斯特大学医学院急诊医学系临床研究教师终身教职的助理教授。候选人于1998年从医学院毕业,获得医学博士学位。自成立以来,他成功地将基础研究(80%的努力)与临床实践(20%的努力)结合起来。为了实现她的职业目标,候选人在这里提出了一个职业发展计划,这将使她能够通过专门设计的课程来获得额外的培训,以教育翻译科学家,作为最近授予CTSA NIH授予我们机构的课程的一部分。此外,候选人将继续追求她在皮肤癌生物学方面的成功研究计划,以及基础科学的高级课程。为此,候选人发现,在UV诱导的皮肤癌中,E-钙粘蛋白(一种介导角质形成细胞之间细胞-细胞接触的粘附分子)的促进性(促癌)下调是一种翻译后事件,首先由细胞外E-钙粘蛋白结构域裂解(主要由MMP)组成,然后是内吞作用和蛋白水解/溶酶体-蛋白酶体降解。此外,候选人已经发现,这一过程是由紫外线辐射损伤后局部释放的PGE 2激活EP 2受体调节的。作为K 08奖项的一部分,候选人将继续她对这一主题的研究,这最终将导致对紫外线诱导的皮肤癌的药理学干预的新靶点的确定。完成拟议的计划将使候选人获得翻译科学硕士学位作为她的K 08奖的一部分。由于拟议培训的多样性,候选人聘请了一个辅导委员会,提供必要的辅导、专门知识和支持。总之,这个K 08奖将为候选人在基础/转化科学的职业生涯做好准备,因此她将能够(1)在实验室的动物模型(临床前研究)中识别新的科学发现及其潜在的临床实用性,(2)通过临床试验评估这些发现,以及(3)将其用于临床实践(从实验室到床边到路边)。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sabine M Brouxhon其他文献

Sabine M Brouxhon的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sabine M Brouxhon', 18)}}的其他基金

A novel multi-targeted therapy for breast cancer resistance
一种新型多靶点乳腺癌耐药疗法
  • 批准号:
    9111810
  • 财政年份:
    2016
  • 资助金额:
    $ 10.67万
  • 项目类别:
A novel multi-targeted therapy for breast cancer resistance
一种新型多靶点乳腺癌耐药疗法
  • 批准号:
    8958353
  • 财政年份:
    2015
  • 资助金额:
    $ 10.67万
  • 项目类别:
sEcad as a novel target and therapy for IGF-1R expressing tumors
sEcad 作为 IGF-1R 表达肿瘤的新靶点和治疗方法
  • 批准号:
    10474581
  • 财政年份:
    2015
  • 资助金额:
    $ 10.67万
  • 项目类别:
sEcad as a novel target and therapy for IGF-1R expressing tumors
sEcad 作为 IGF-1R 表达肿瘤的新靶点和治疗方法
  • 批准号:
    8962751
  • 财政年份:
    2015
  • 资助金额:
    $ 10.67万
  • 项目类别:
sEcad as a novel target and therapy for IGF-1R expressing tumors
sEcad 作为 IGF-1R 表达肿瘤的新靶点和治疗方法
  • 批准号:
    10249513
  • 财政年份:
    2015
  • 资助金额:
    $ 10.67万
  • 项目类别:
sEcad as a novel target and therapy for IGF-1R expressing tumors
sEcad 作为 IGF-1R 表达肿瘤的新靶点和治疗方法
  • 批准号:
    10356177
  • 财政年份:
    2015
  • 资助金额:
    $ 10.67万
  • 项目类别:
sEcad as a novel target and therapy for IGF-1R expressing tumors
sEcad 作为 IGF-1R 表达肿瘤的新靶点和治疗方法
  • 批准号:
    9333095
  • 财政年份:
    2015
  • 资助金额:
    $ 10.67万
  • 项目类别:
PG's and Keratinocyte Adhesion
PG 和角质形成细胞粘附
  • 批准号:
    7686824
  • 财政年份:
    2008
  • 资助金额:
    $ 10.67万
  • 项目类别:
PG's and Keratinocyte Adhesion
PG 和角质形成细胞粘附
  • 批准号:
    8258808
  • 财政年份:
    2008
  • 资助金额:
    $ 10.67万
  • 项目类别:
PG's and Keratinocyte Adhesion
PG 和角质形成细胞粘附
  • 批准号:
    7471012
  • 财政年份:
    2008
  • 资助金额:
    $ 10.67万
  • 项目类别:

相似海外基金

Evidence-Based Dialogue to Promote Sun Protection, Foster a Community of Concern and Increase Awareness for Skin Cancers in Canada.
在加拿大开展基于证据的对话,以促进防晒、培养关注社区并提高对皮肤癌的认识。
  • 批准号:
    485622
  • 财政年份:
    2023
  • 资助金额:
    $ 10.67万
  • 项目类别:
    Miscellaneous Programs
The role of GPR84 signaling during skin repair
GPR84 信号在皮肤修复中的作用
  • 批准号:
    10637039
  • 财政年份:
    2023
  • 资助金额:
    $ 10.67万
  • 项目类别:
Patient oriented research and mentoring program in dermatologic diseases
以患者为中心的皮肤病研究和指导计划
  • 批准号:
    10685455
  • 财政年份:
    2023
  • 资助金额:
    $ 10.67万
  • 项目类别:
Prevention of intracellular infection in diabetic wounds by commensal Staphylococcus epidermidis
共生表皮葡萄球菌预防糖尿病伤口细胞内感染
  • 批准号:
    10679628
  • 财政年份:
    2023
  • 资助金额:
    $ 10.67万
  • 项目类别:
Tissue-Anchored vs. Circulating Engineered Enzyme Constructs for Immunometabolic Resolution of Psoriasis
组织锚定与循环工程酶构建体用于银屑病免疫代谢解决
  • 批准号:
    10667165
  • 财政年份:
    2023
  • 资助金额:
    $ 10.67万
  • 项目类别:
A role of balanced sex hormone in DNA repair in human melanocytes
平衡性激素在人类黑素细胞 DNA 修复中的作用
  • 批准号:
    10666307
  • 财政年份:
    2023
  • 资助金额:
    $ 10.67万
  • 项目类别:
Malassezia and Candida auris: skin microbiome dysbiosis and de-regulation of cutaneous homeostasis
马拉色菌和耳念珠菌:皮肤微生物群失调和皮肤稳态失调
  • 批准号:
    10661959
  • 财政年份:
    2023
  • 资助金额:
    $ 10.67万
  • 项目类别:
Advancing skin cancer prevention by tackling UV-induced clonogenic mutations
通过应对紫外线诱导的克隆突变来促进皮肤癌的预防
  • 批准号:
    10829054
  • 财政年份:
    2023
  • 资助金额:
    $ 10.67万
  • 项目类别:
A First-in-class Topical Immunoregulatory Therapeutic for Psoriasis
一流的牛皮癣局部免疫调节疗法
  • 批准号:
    10820331
  • 财政年份:
    2023
  • 资助金额:
    $ 10.67万
  • 项目类别:
Pre-clinical testing of low intensity ultrasound as novel strategy to prevent paclitaxel-induced hair follicle damage in a humanized mouse model of chemotherapy-induced alopecia
低强度超声的临床前测试作为预防化疗引起的脱发人源化小鼠模型中紫杉醇引起的毛囊损伤的新策略
  • 批准号:
    10722518
  • 财政年份:
    2023
  • 资助金额:
    $ 10.67万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了